What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Medical Device

Catheter Equipment

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1639097

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1639097

Global Bioresorbable Coronary Stents Market Size Study, by Material (Polymer, Metal), Drug (Sirolimus, Novalimus), End Use (Outpatient, Inpatient Facilities), and Regional Forecasts 2022-2032

PUBLISHED: January 16, 2025

PAGES: 285 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The Global Bioresorbable Coronary Stents Market, valued at approximately USD 158.12 million in 2023, is poised to grow steadily at a CAGR of 4.10% over the forecast period 2024-2032. These innovative stents, made from bioresorbable materials, dissolve over time, reducing complications associated with permanent implants. Their capacity to restore normal blood flow in coronary arteries while eliminating the long-term presence of foreign materials underscores their importance in cardiovascular interventions.

The market's expansion is fueled by increasing prevalence of cardiovascular diseases globally and a growing preference for minimally invasive treatments. Bioresorbable stents, with advancements in polymer and metal technologies, are meeting the clinical demand for safer, more effective alternatives to conventional stents. Sirolimus and Novalimus drug coatings further enhance stent performance by minimizing restenosis and inflammation post-implantation. The steady shift toward outpatient facilities for procedures is also bolstering market dynamics by offering cost-effective and patient-friendly solutions.

While high costs and stringent regulatory approvals remain challenges, significant research and development efforts are underway to address these concerns. Advancements in material science and clinical trials demonstrating long-term efficacy and safety are driving broader acceptance among healthcare professionals and patients. Emerging markets in Asia-Pacific and Latin America, with rising healthcare investments and awareness, represent untapped opportunities for the bioresorbable coronary stents industry.

Regionally, North America dominates the market owing to its advanced healthcare infrastructure, strong focus on innovation, and high incidence of cardiovascular diseases. Europe closely follows, driven by supportive government policies and well-established cardiac care facilities. The Asia-Pacific region, with its burgeoning economies and increasing focus on advanced medical devices, is expected to exhibit the fastest growth over the forecast period.

Major market players included in this report are:

Abbott Laboratories
Boston Scientific Corporation
Medtronic Plc
Terumo Corporation
Biotronik SE & Co. KG
Meril Life Sciences Pvt. Ltd.
Elixir Medical Corporation
OrbusNeich
Lepu Medical Technology (Beijing) Co., Ltd.
Amaranth Medical, Inc.
Reva Medical, Inc.
Kyoto Medical Planning Co., Ltd.
C.R. Bard, Inc.
Stentys SA
SMT (Sahajanand Medical Technologies)

The detailed segments and sub-segment of the market are explained below:

By Material:

Polymer
Metal

By Drug:

Sirolimus
Novalimus

By End Use:

Outpatient
Inpatient Facilities

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe

Asia Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Latin America:

Brazil
Mexico

Middle East & Africa:

Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market estimates and forecasts spanning 2022-2032.
Annualized revenues with detailed regional and segment analysis.
Insights into critical market drivers, challenges, and opportunities.
Profiles of leading market players and analysis of key strategies.
Regional and global trends shaping the future of bioresorbable coronary stents.

Chapter 1. Global Bioresorbable Coronary Stents Market Executive Summary

1.1. Global Bioresorbable Coronary Stents Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Material
  - 1.3.1.1. Polymer
  - 1.3.1.2. Metal
- 1.3.2. By Drug
  - 1.3.2.1. Sirolimus
  - 1.3.2.2. Novalimus
- 1.3.3. By End Use
  - 1.3.3.1. Outpatient
  - 1.3.3.2. Inpatient Facilities
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Bioresorbable Coronary Stents Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Bioresorbable Coronary Stents Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Cardiovascular Diseases
- 3.1.2. Growing Preference for Minimally Invasive Treatments
- 3.1.3. Advancements in Material and Drug Technologies
3.2. Market Challenges
- 3.2.1. High Costs Associated with Bioresorbable Stents
- 3.2.2. Stringent Regulatory Approvals
3.3. Market Opportunities
- 3.3.1. Innovations in Device Design
- 3.3.2. Increasing Demand in Pediatric Care
- 3.3.3. Regional Investments in Healthcare Infrastructure

Chapter 4. Global Bioresorbable Coronary Stents Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Bioresorbable Coronary Stents Market Size & Forecasts by Material 2022-2032

5.1. Segment Dashboard
5.2. Global Bioresorbable Coronary Stents Market: Material Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Polymer
- 5.2.2. Metal

Chapter 6. Global Bioresorbable Coronary Stents Market Size & Forecasts by Drug 2022-2032

6.1. Segment Dashboard
6.2. Global Bioresorbable Coronary Stents Market: Drug Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Sirolimus
- 6.2.2. Novalimus

Chapter 7. Global Bioresorbable Coronary Stents Market Size & Forecasts by End Use 2022-2032

7.1. Segment Dashboard
7.2. Global Bioresorbable Coronary Stents Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Outpatient
- 7.2.2. Inpatient Facilities

Chapter 8. Global Bioresorbable Coronary Stents Market Size & Forecasts by Region 2022-2032

8.1. North America Bioresorbable Coronary Stents Market
- 8.1.1. U.S. Bioresorbable Coronary Stents Market
  - 8.1.1.1. Application Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.2. Patient Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.3. End Use Breakdown Size & Forecasts, 2022-2032
- 8.1.2. Canada Bioresorbable Coronary Stents Market
8.2. Europe Bioresorbable Coronary Stents Market
- 8.2.1. UK Bioresorbable Coronary Stents Market
- 8.2.2. Germany Bioresorbable Coronary Stents Market
- 8.2.3. France Bioresorbable Coronary Stents Market
- 8.2.4. Spain Bioresorbable Coronary Stents Market
- 8.2.5. Italy Bioresorbable Coronary Stents Market
- 8.2.6. Rest of Europe Bioresorbable Coronary Stents Market
8.3. Asia-Pacific Bioresorbable Coronary Stents Market
- 8.3.1. China Bioresorbable Coronary Stents Market
- 8.3.2. India Bioresorbable Coronary Stents Market
- 8.3.3. Japan Bioresorbable Coronary Stents Market
- 8.3.4. Australia Bioresorbable Coronary Stents Market
- 8.3.5. South Korea Bioresorbable Coronary Stents Market
- 8.3.6. Rest of Asia Pacific Bioresorbable Coronary Stents Market
8.4. Latin America Bioresorbable Coronary Stents Market
- 8.4.1. Brazil Bioresorbable Coronary Stents Market
- 8.4.2. Mexico Bioresorbable Coronary Stents Market
- 8.4.3. Rest of Latin America Bioresorbable Coronary Stents Market
8.5. Middle East & Africa Bioresorbable Coronary Stents Market
- 8.5.1. Saudi Arabia Bioresorbable Coronary Stents Market
- 8.5.2. South Africa Bioresorbable Coronary Stents Market
- 8.5.3. Rest of Middle East & Africa Bioresorbable Coronary Stents Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Abbott Laboratories
- 9.1.2. Boston Scientific Corporation
- 9.1.3. Medtronic Plc
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Abbott Laboratories
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Boston Scientific Corporation
- 9.3.3. Medtronic Plc
- 9.3.4. Terumo Corporation
- 9.3.5. Biotronik SE & Co. KG
- 9.3.6. Meril Life Sciences Pvt. Ltd.
- 9.3.7. Elixir Medical Corporation
- 9.3.8. OrbusNeich
- 9.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
- 9.3.10. Amaranth Medical, Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes